Trial: 202105140

Phase 1/1B study of DS-8201a in combination with ATR Inhibition (AZD6738) in advanced solid tumors with HER2 expression (DASH Trial)

Phase

I

Principal Investigator

Grierson, Patrick

Disease Site

Breast; Colon; Corpus Uteri; Esophagus; Lip, Oral Cavity and Pharynx; Liver; Other Digestive Organ; Rectum; Stomach

Learn more about this study at: clinicaltrials.gov